Free Answering Brief in Opposition - District Court of Delaware - Delaware


File Size: 89.4 kB
Pages: 3
Date: August 22, 2005
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 932 Words, 6,873 Characters
Page Size: 612 x 794 pts
URL

https://www.findforms.com/pdf_files/ded/7526/112-4.pdf

Download Answering Brief in Opposition - District Court of Delaware ( 89.4 kB)


Preview Answering Brief in Opposition - District Court of Delaware
- Case 1:04-cv-00174-JJF Document 112-4 Filed 08/22/2005 Page 1 of 3
EXHIBIT 3

Case 1 :04-cv-00174-JJF Document 1 12-4 Filed 08/22/2005 Page 2 of 3
. [ ANIMAL REPURT I 2¤n1.2o¤3
Letter fm m the Cha nrman
......................,....,............. Q .........................................................,.............,................................................
V ·`_ , » wggéliii g
·‘ - 1‘‘` n o 5
{ __.-_ ng 1 uu ytmnd an present mms mw xenon lu: me yw ended in june 2003. ms
mqm mms z successful ye: of operations kn- ihc Gumpuny amd Shmimkinrs ziikc.
__¤ Hmeiy accomplishment of the corpnmau ubicctivcs lhroughsvut thc yea: has ruukcd in
L the Gompzngfs strong slur: pcofumnncc, despite as backdrop nf poor market mmiirions
‘ T ii fn: bod: Auumlm and inenmzinmi bxueudmniugy companies.
1* In dw nm mar or nu yur, we gm me umm nun cf me sunnams, mus and
_ __ {_ _ _ Eizbiéitics of me former Queensland Gpnls mining unity, Iming Buaiux: as an mnirsiy
biowchnoiugy iocused company
111mugh¤u1:bcy¤r,mmgu¤¤uhasmn¤mn¤z¤dissactisi5<=B1twcn¤lna:ug
pufusiugandmiargngmuudlummipmpuqeporifdicmdizkmulyingthcissnc
sugars upon which du: Company wlé conounumz Hs Eutnrc hmmm tbuupcmic
pwmvwnc
11wummdBcu12c¥bma&mdd¤mmmtimd1cc¤x:3gn·npc1qp0si§un,I»acds»pmm
1 §££$mdb!0Wh0W§0E¢fSBd\h££ihUSill¤G$m0ddW*liCbiSV¤Y5HH¤3EffDmm¤$Z
Q osha: hhmdmdugy mmpmis. Through both exclusive licensing mlazionships and
&:¤¤|y,B¤1inc¤i1|daiwH¤m§ngmmue{mm§1kdp¤¤¤susi1ngd1isudmd¤g;·ma
wdMdchw¤s.ms:w¤1uuiHo§s¤u:eCozupa¤y‘scpu2¤cn¤!ccs:s,uw¤Has
cunmbmcwahemszdizsshmpwvicdwdqummzpmgnmumc Thlshasdzndsnleieu
ofpmiémgc¤h&ow{¤¢thcCnmpn¤y;whiI¤As¤s:bstanHz¤ymduch:gbcu:cdIw
and frequency of fssudsziskng We are lmldng to ndncwe increased shnrdxoécicr
nlue by reducing the normal aiiluziun prow thai is amocimcd with du: uuddtimul
biotechnology dmciopmmr and fundraising .
The room! gviddincs on cmpunnc governance higbiiglu dm raced for incruascd imcmal
ng1bncc¤ndusnsparmcy£n¤cumpnny'saHai:sWc1mcunumucdwb¤¤pm¤iwia1
this imgmnsns ma and we wili continue no impiement proccssu which wm lumber
proton rhcinsu-uns ui our shasencldus
We tnrd»2003£nmcizlyuruithEncr¤mdccx¤In:yasLo¤1c1nn;us1‘t¤¤ccmd
widespread npplicaiion of our mdnolngy and with identities! spu:E5c disease mgcss
which will fom the basis of our in-house commercial rcsunrch pmgrmmc. Our
objcctiw {ur 2005/201}*1 an: no less ambitious than for thc past yur and we are
cummiuod to achieving than. Qur naive: public réatluns programme will cns¤rc that you
arekepcrcguhdyzpprzisod ofour achievements.
End}; I dunk al} of my m-Diruxmrs and nur cmpioyacs for their unstinting support to
Bcniicc ove: the pas: ycan lbazir work im laid a su-cmg fnunclanun for the success of
Bcuiitcc in the future.

_,&>bnA J·!cX?nl¢g·
Ezreculim Chairman
iii

Case 1 :04-cv-00174-JJF Document 1 12-4 Filed 08/22/2005 Page 3 of 3
semen umm and ennuuladimuea I IIIIIIEIL ntrtm { mmm;
B ` ’ B ` ·
E·lll'[9C S USlll€SS lcmml

intellectual Property `
Swmi wm kdm: me g1ubaE sdcmihc cosurnumzy accepted 8'IE reality of RSA1 in uaxmzsnlm cells,
Bcnilcc was the Em to show Bae universality uf REAL by demcmmaing dmc d¤~¤m·r•.-gu1·atl0u uf tugd gene
expxminn Ln human aud mamnuiiau cells, inventing 1 rdiabkz mms of uigerlng me im} pmcw
uslngDN.&¤¤¤1s:¤:¤s.Be¤§tec'sc¤repztentsmh¤scd¤ad1isc1d~;rescardnu¤du¢suppcr\¤dh1
subsequent tiling: aha: mend cha-: scape and iumdlcuun nfits [fund the milky of its zedmaiogr.
Bm1¤ec‘spm¤¤1es¢zr¤ repeuenuuiusuiaanuposiunn IBDNA-dircuedgwesilmdngsndgumsnhythc
duuénanxposlkmlnRNAi:ppli¤z1ousf0rlmms¤smd¤wuuuh:.0ujm1e4¤:dS,200?•,dac&1·¤5 -
andL¥Kpsuc1usf¤r1hz¤ppB¤1i¤nufR¤*lAh1turfa:tn¤:\¤ma:m:¤i¤¤ cdlswerexwudcd t¤Bcr¤Iec.
Management Team and Responsibilities
Benitac Limited and group Exacutlva Chalrman and CEO
_luImMclGnl:ywas:pp0i¤1z·éEnMa1·ch2£K3l 8H'lFdB\“If2m2$k¢CU\}'|'E(3l$.}¥DH¤2Ild»Kd.
¤ ahenewccmbl:1c¢Eg~¤up.\l*llh¤»1:r |$Yc¤!S¤perle11cel¤§1¤I¤!cm¤§u¤Ibi0¢cchnu]¤gy!¤d:.•s:·y¤s
i dhreunrmduwafpublicmdprmmcmngnmcssndsbujzgmuudassscllchnrspudalhingm
intellectual Progeny and Corporal: law, }¤b¤ has upemuce of bullding md cvmmesdaiizing
iauemnlunai ¤mps.ni¤s.}¤l*m Im wmii rarponsihlilzy bull nspects ul the g·¤¤p‘s devdnpmmt.
Research and Development and EP
DrKmRud,¤cm&vedbc¤m¤fBml1mlhumd,h¤mm$h:n2D}¤¤:sr¤c¤¤hmddmd¤pmuzt
cxp¤1mmmA¤uu¤Jhmdmmus:ndkmlmmmd}yr¤g¤dc6m&»¤b£¤wch11dcgg¤hd1m:y He
hu published mmsimlyln scimulhc am mchniml jnumzhs mdhns mthcmd seven! bucks md QED];.
Drilucd dire¤snndmmaguaIl¤fBeulwc':R&Dp:¤;v¤ma¤GIPporL%¤!i¤. Drkecdbsuppcnndbybr
Peter Goss, Corporal: and Prulcci Manager. Dr Goss lm 1 Phbfmm Harvard Univusltym ¤dc§!ng
g¤1¤$1cnetw¤rks,m¤11crgiugarc¤cfbi¤lnfoama¤J¤. Hehaswurkndlnsuwlqccnndlhzgand change
msmzgemenx In Lnmdmz and the Nedzcmaus. ile manages Bczxcuct implcmumrtun ¤(sdemlBc psalms.
Furvlmrelmik mz semen m—u¤g5,:¤1¤11¤m¤;l prcpcnymdkdmnbgun ht [cum! on mhewzbstus
vmahcniwamm.
Maw mmnwmzww qzmunmnmummuurusuanmuwdmwnpvmmumuw
awnmuag-m:»mAs;
Bm!mb¤»w¤dmdh»&pnmwn4¤qi»&rb¤hmqfhdqiqp¤pw¤ymh¤kp·:dh¤h·hdPhpv§
{puma} 3•s£ia¢H•¤b••¤I¢g•·&§•¤ni¤¢gene:daa:£agu ‘k.•\§U»t•nj?rna¤'
(!¢‘i¤l.•].¢¤»dur¤W3·¤¤wniqg¢~d¥dm·¤sduim$¤m¤hthmlH¤¥R#;g’;m¢j¢gmuMbmm.n!n¢nl
piuun §¤n!h¤cm¤w:$anwn:ba_li::!Jviurm¤»u¤e|§¢;r¤¤L¤c#gv£¤k.¥Us¤i:J¤ uaamah ftedmupuay
s6umdI.Msh•¤¤¤mdk1u¤&'¤#w¤inI9‘)i9.m¤·¢H£i¢!»m¤¤m3hI!I¥.
1m»r:·.·p¤¤¤u¤»a·¤»us¤·q»_;¤•r;s¤•¤:¤;»¤v»»n;;-¢¤ ::2x¤¤m.¤w&¤u»m¤mmdqy:&hq»·,wm:¤¤¤
mmmwgwqmm.
22

Case 1:04-cv-00174-JJF

Document 112-4

Filed 08/22/2005

Page 1 of 3

Case 1:04-cv-00174-JJF

Document 112-4

Filed 08/22/2005

Page 2 of 3

Case 1:04-cv-00174-JJF

Document 112-4

Filed 08/22/2005

Page 3 of 3